Massey Ventures Limited is a wholly owned subsidiary of Massey University. Our role is to commercialise intellectual property and innovative research within the University. To achieve this, we work with Massey researchers and inventors to guide them through the commercialisation process and turn their innovative ideas into real-world commercial opportunities.
We also provide access to early stage investment to support the development of commercially promising ideas. Massey Ventures also holds equity in a range of companies that have been spun out of the University.
Mark is the former Director of Business Development and Commercialisation at Massey University. Prior to joining Massey University in 2008, Mark spent 10 years with Crown Research Institute Landcare Research. Mark has a particular interest in innovation and the commercialisation of research and has helped establish several new companies. In 2005 he co-founded his own business Aero Sports Protection Ltd, a sports equipment manufacturing and distribution business.
Dr Russell Wilson
Commercialisation and IP Manager
Russell is the Commercialisation and IP Manager at Massey University. Prior to joining Massey in 2010, Russell spent 25 years working in the NZ dairy industry in a range of research and development roles ranging from research scientist through to R&D management. Russell has a strong interest in the commercialisation of research, particularly in the food and agritech space.
Senior Strategic Commercialisation Advisor
Rick is an experienced Business Advisor with over 25 years experience in large corporate environments both here in NZ and overseas . His last international corporate role was VP-Commercial Development, Asia Pacific for GSK (GlaxoSmithKline). Recently, Rick has successfully closed two substantial international IP agreements for NZ organisations. Rick brings valuable experience and expertise in business commercialisation, business valuations and contract negotiations.
Dr Sean Mackay
Senior Commercialisation Manager
Sean is a Senior Commercialisation Manager at Massey University. Prior to Massey he completed a PhD and Postdoctoral Research Fellowship at the University of Otago developing drug delivery technologies for the treatment of disfiguring strawberry birthmarks and neurological disorders. Sean has a strong interest in the commercialisation of research, particularly in the biotechnology and pharmaceutical space, and is an advisor to multiple biotechnology and life science companies.
Dan is PhD student at Massey University and a commercialisation manager for Massey Ventures. Prior to joining the team, Dan was a research associate Consumer Insights Ltd with experience in branding, market research, and graphic design. Dan also sits on the Manawatū Momentum Investment Committee.
Ella is a commercialisation analyst at Massey Ventures with a Bachelor of Business majoring in International Business and Strategic Communication. She has strong interests in start-ups, enterprise, and commercialization and sits on the Manawatū Momentum Investment Committee.
Dr Gavin Clark
Dean of Enterprise
Gavin is Dean of Enterprise at Massey University and has a background in industrial micro-biology obtaining his PhD in 1993 at the University of Surrey. Gavin has served a variety of roles in universities and spinout companies in including Director of Commercialisation at Massey, CEO of Polybatics Ltd, Industrial Liaison Director at the UK Industrial Doctorate Centre at Newcastle University, and Director of Research & Enterprise at the University of Otago.
Terry is currently a Trade Commissioner for New Zealand Trade and Enterprise. Prior to joining NZTE he was the managing director of Allen Strategic, a company he founded specialising in the provision of governance, strategy and execution services at board and executive level. Terry has 20 years’ experience in the wider ICT industry, during which he has held senior roles in multinational technology companies, including 12 years with Microsoft New Zealand. He also ran the incubation business for Auckland University's Icehouse incubator for two years, focusing on business growth strategy, business start-ups, commercialisation and company governance. Terry holds a number of directorships and is currently on the board of Serato, Theta Systems, Massey Ventures Ltd and MPA Limited.
Professor Giselle Byrnes brings to the Board senior management experience in universities in Australia and in New Zealand and a broad knowledge of governance across the higher education and community sectors. Giselle is an internationally recognised historian and joined Massey in early 2016. She brings a particular expertise in academic governance and accountability and in the performing arts boards and governance sector. Professor Byrnes has been Fulbright scholar teaching New Zealand Studies at Georgetown University, Washington DC, and has served as President of the New Zealand Historical Association. She has a commitment to advancing the agenda around equity and access to higher education and is a strong advocate of the critical role played by modern universities in creating social, cultural and intellectual capital for public benefit and economic wellbeing.
Carolyn is the Chief Financial Officer at Massey University and brings significant financial and commercial acumen and experience to the Board. Carolyn sits on a number of boards including some of Massey Ventures' subsidiaries, Massey’s internationalisation subsidiaries, and is an member elected board member on UniSaver Limited, the NZ University Sector Superannuation Scheme. Prior to joining Massey Carolyn was an Executive Director at EY working with a number of Tertiary Institutes, Public, and Private Sector organisations in New Zealand and the UK.
Andrew is currently lead partner at Auckland based Andrew Lewis Law. Andrew has 15 years' of partner level experience at leading New Zealand and international firms (12 years as a corporate partner at Simpson Grierson in Auckland and three years as a corporate partner at Norton Rose Group in Dubai). He has led major transactions including mergers and acquisitions, investment transactions, capital raisings and funds, joint ventures and supply and distribution arrangements. In many cases these transactions cross international borders with a particular focus on the Asia Pacific, Middle East and Africa regions.